Advertisement
Advertisement

ATRC

ATRC logo

AtriCure, Inc.

29.98
USD
Sponsored
+0.45
+1.53%
Mar 26, 15:59 UTC -4
Closed
exchange

After-Market

30.00

+0.01
+0.05%

AtriCure, Inc. Profile

About

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.

Info & Links

CEO

Michael H. Carrel

Headquarters

7555 INNOVATION WAY
MASON, OH 45040, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

55

Employees

330

AtriCure, Inc. Statistics

Valuation Measures

Market Capitalization2

1.49B

Enterprise Value

1.39B

Enterprise Value/EBITDA(ttm)

120.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.76

Price to Book(mrq)

2.99

Price to Cash(ytd)

94.60

Profitability

Gross Margin(ttm)

74.98%

Operating Margin(ttm)

-1.02%

Profit Margin(ttm)

-2.24%

Return on Equity(ttm)

-1.15%

Return on Invested Capital(ttm)

-2.16%

Return on Assets(ttm)

-0.88%

Income Statement

Revenue(ttm)

534.53M

Revenue Per Share(ttm)

10.73

Gross Profit(ttm)

400.78M

EBITDA(ttm)3

11.56M

Net Income Available to Common(ttm)

-11.45M

Diluted EPS(ttm)

-0.24

Share Statistics

Beta (5Y Monthly)

1.42

52-Week Change

-13.97%

S&P 500 52-Week Change

13.77%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

49.81M

Dividend Yield

0.00%

Float4

48.07M

% Held by Insiders

3.50%

% Held by Institutions

99.11%

Balance Sheet

Total Cash(mrq)

167.43M

Total Cash Per Share(mrq)

3.36

Total Debt(mrq)

61.87M

Total Debt/Equity(mrq)

12.58%

Current Ratio(mrq)

3.96%

Quick Ratio(mrq)

2.99%

Book Value Per Share(mrq)

9.88

Cash Flow

Operating Cash Flow Per Share(ytd)

1.20

Free Cash Flow(ytd)

48.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement